Isotopically marked quinoline derivatives as adenosin A3 receptor ligands

Details for Australian Patent Application No. 2005303544 (hide)

Owner Sanofi-Aventis

Inventors Tomboly, Csaba; Boer, Kinga; Toth, Geza; Timari, Geza

Agent Watermark

Pub. Number AU-B-2005303544

PCT Pub. Number WO2006/051341

Priority P0402371 15.11.04 HU

Filing date 9 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 2 June 2011

International Classifications

C07D 215/54 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07F 7/22 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/051341 Priority application(s): WO2006/051341

2 June 2011 Application Accepted

  Published as AU-B-2005303544

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303550-Level sensor extracting its operating power from an indicating instrument

2005303541-Fabric structure comprising silvergermanium-copper alloy